Recruiting

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(83 sites)

United States

Kaiser Permanente Center, Vallejo, California

Northside Hospital, Atlanta, Georgia

St. Joseph, Savannah, Georgia

Dr. Sudarshan K. Sharma, Ltd., Hinsdale, Illinois

Parkview Research Center, Fort Wayne, Indiana

Indiana University, Indianapolis, Indiana

Maryland Oncology Hematology, P.A., Silver Spring, Maryland

Minnesota Oncology Hematology, P.A., Minneapolis, Minnesota

Washington University School of Medicine, St Louis, Missouri

Women's Cancer Center of Nevada, Las Vegas, Nevada

Good Samaritan Hospital Medical Center, West Islip, New York

FirstHealth Carolinas, Pinehurst, North Carolina

OhioHealth Institute, Columbus, Ohio

Oklahoma Cancer Specialists and Research Institute, Tulsa, Oklahoma

Oncology Associates of Oregon, Eugene, Oregon

Northwest Cancer Specialists, Portland, Oregon

Texas Oncology-Austin Central, Austin, Texas

Texas Oncology-Fort Worth Cancer Center, Fort Worth, Texas

Texas Oncology-San Antonio Medical Center, San Antonio, Texas

Austria

University Hospital Graz, Department of Gynecology and Obstetrics, Graz

Medizinische Universität Innsbruck, Innsbruck

Medizinische Universität Wien, Vienna

Canada

Cross Cancer Institute, Edmonton

CHUM - University of Montreal Hospital Centre, Montreal

Denmark

Odense University Hospital, Odense

Estonia

Tartu University Hospital, Tartu

Finland

Kuopio University Hospital, Kuopio

Turku University Hospital, Turku

Georgia

LTD High Technology hospital Medcenter, Batumi

American Hospital Network LLC, Tbilisi

Caucasus Medical Centre, Tbilisi

Hungary

National Institute of Oncology, Budapest

University of Debrecen Clinical Center, Debrecen

Israel

Rambam Medical Center, Haifa

Shaare Zedek Medical Center, Jerusalem

Sourasky Medical Center, Tel Aviv

Italy

A.O. Cannizzaro, Catania

IRCCS Istituto Romangolo per lo Studio dei Tumori "Dino Amadori", Forlì

Ospedale Policlinico San Martino, Genoa

ASST di Lecco-Ospedale Alessandro Manzoni, Lecco

Ospedale San Luca, Lucca

Osp. Niguarda, Milan

University Hospital of Parma, Parma

Ospedale Guglielmo da Saliceto, Piacenza

Ospedale di Prato S. Stefano, Prato

Ospedale Santa Maria delle Croci, Ravenna

"Azienda Unità Sanitaria Locale della Romagna - Hospital ""Infermi"" of Rimini Oncology Department", Rimini

Policlinico Umberto, Rome

Ospedale Filippo Del Ponte, Varese

Lithuania

Health Sciences Kaunas Clinics, Kaunas

Nation Cancer Institute of Lithuania, Vilnius, Vilnius

Norway

Southern Hospital Sorlandet, Kristiansand

Oslo University Hospital HF, Oslo

Sykehusapotek Nord Tromsø, Tromsø

Poland

Białostockie Centrum Onkologii, Bialystok

Szpitale Pomorskie, Gdansk

Uniwersyteckie Centrum Kliniczne, Gdansk

NIO-PIB Oddzial w Gliwicach, Gliwice

Centrum Badań klinicznych Jagiellońskie Centrum Innowacji, Krakow

Siedleckie Centrum Onkologii, Olsztyn

Uniwersytecki Szpital, Poznan

NIO-PIB Klinika Gine-Onk, Warsaw

Lower Silesian Oncology, Pulmonology and Hematology Center, Department of Oncological Gynecology, Wroclaw

Romania

Bucharest CF2 Hospital, Bucharest

Ovidius Clinical Hospital SRL, Constanța

Onco Clinic Consult S.A., Craiova

Oncology Center "Sf. Nectarie", Craiova

Gral Medical S.R.L. - Oncofort Hospital, Piteşti

Oncocenter, Oncology Clinic SRL, Timișoara

SC Oncomed SRL, Timișoara

Slovenia

Institute of Oncology Ljubljana, Ljubljana

University Clinical Center Maribor, Maribor

Spain

CHUAC (Hospital de Coruña), A Coruña

Hospital del Mar, Barcelona

Hospital Galdakao-Usansolo, Galdakao

Hospital Universitario de Jaen, Jaén

H.G.U. Jerez de la Frontera, Jerez de la Frontera

Hospital U Insular de GC, Las Palmas

Hospital de Leon, León

HCU Santiago de Compostela, Santiago de Compostela

Hospital Universitario de Valme, Seville

Sweden

Linkoping University Hospital, Linköping

Karolinska University Hospital, Stockholm

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

Trial locations(83 sites)

Interested in joining?